Development of high‑resolution melting analysis for ABCB1 promoter methylation: Clinical consequences in breast and ovarian carcinoma

  • Authors:
    • Radka Vaclavikova
    • Jovana Klajic
    • Veronika Brynychova
    • Katerina Elsnerova
    • Grethe I.G. Alnaes
    • Jörg Tost
    • Vessela N. Kristensen
    • Lukas Rob
    • Roman Kodet
    • Petr Skapa
    • Marcela Mrhalova
    • Pavel Soucek
  • View Affiliations

  • Published online on: June 5, 2019     https://doi.org/10.3892/or.2019.7186
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Multidrug resistance to anticancer drugs, which is often associated with enhanced expression of the ATP‑binding cassette (ABC) transporter P‑glycoprotein (encoded by the ABCB1 gene) may limit the effects of cancer therapy. Epigenetic regulation of ABCB1 expression may thus have a clinical impact. A detailed assessment of ABCB1 promoter methylation is of importance for predicting therapy outcome and prognosis. Thus, validated methods for the analysis of ABCB1 promoter methylation are urgently required. In the present study, high‑resolution melting (HRM) analysis of the CpG island regions covering the distal promoter of the ABCB1 gene was developed and compared with pyrosequencing. In addition, the clinical effects of the methylation status of the ABCB1 promoter were analyzed in patients with breast and ovarian carcinoma prior and subsequent to chemotherapy treatment. HRM analysis of ABCB1 methylation correlated with the results of pyrosequencing (P=0.001) demonstrating its analytical validity and utility. Hypermethylation of the analyzed ABCB1 promoter region was significantly correlated with low levels of the ABCB1 transcript in tumors from a subset of patients with breast and ovarian carcinoma prior to chemotherapy but not following treatment. Finally, high ABCB1 transcript levels were observed in tumors of patients with short progression‑free survival prior to chemotherapy. Our data suggest the existence of functional epigenetic changes in the ABCB1 gene with prognostic value in tumor tissues of patients with breast and ovarian carcinoma. The clinical importance of such changes should be further evaluated.

Related Articles

Journal Cover

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Vaclavikova, R., Klajic, J., Brynychova, V., Elsnerova, K., Alnaes, G.I., Tost, J. ... Soucek, P. (1899). Development of high‑resolution melting analysis for ABCB1 promoter methylation: Clinical consequences in breast and ovarian carcinoma. Oncology Reports, 0, 0-0. https://doi.org/10.3892/or.2019.7186
MLA
Vaclavikova, R., Klajic, J., Brynychova, V., Elsnerova, K., Alnaes, G. I., Tost, J., Kristensen, V. N., Rob, L., Kodet, R., Skapa, P., Mrhalova, M., Soucek, P."Development of high‑resolution melting analysis for ABCB1 promoter methylation: Clinical consequences in breast and ovarian carcinoma". Oncology Reports 0.0 (1899): 0-0.
Chicago
Vaclavikova, R., Klajic, J., Brynychova, V., Elsnerova, K., Alnaes, G. I., Tost, J., Kristensen, V. N., Rob, L., Kodet, R., Skapa, P., Mrhalova, M., Soucek, P."Development of high‑resolution melting analysis for ABCB1 promoter methylation: Clinical consequences in breast and ovarian carcinoma". Oncology Reports 0, no. 0 (1899): 0-0. https://doi.org/10.3892/or.2019.7186